BlackRock’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159M Buy
13,666,850
+1,437,057
+12% +$16.7M ﹤0.01% 1738
2025
Q1
$90.9M Buy
12,229,793
+108,947
+0.9% +$809K ﹤0.01% 2032
2024
Q4
$72.7M Buy
12,120,846
+188,005
+2% +$1.13M ﹤0.01% 2216
2024
Q3
$61.1M Buy
11,932,841
+268,839
+2% +$1.38M ﹤0.01% 2328
2024
Q2
$42.2M Buy
11,664,002
+473,883
+4% +$1.72M ﹤0.01% 2481
2024
Q1
$35.9M Sell
11,190,119
-231,435
-2% -$743K ﹤0.01% 2596
2023
Q4
$56M Sell
11,421,554
-163,554
-1% -$801K ﹤0.01% 2366
2023
Q3
$63.1M Buy
11,585,108
+102,521
+0.9% +$559K ﹤0.01% 2235
2023
Q2
$77M Sell
11,482,587
-285,854
-2% -$1.92M ﹤0.01% 2190
2023
Q1
$104M Sell
11,768,441
-605,756
-5% -$5.35M ﹤0.01% 1971
2022
Q4
$94.5M Buy
12,374,197
+2,254,788
+22% +$17.2M ﹤0.01% 2023
2022
Q3
$72.1M Buy
10,119,409
+1,098,301
+12% +$7.82M ﹤0.01% 2152
2022
Q2
$73M Buy
9,021,108
+3,054,607
+51% +$24.7M ﹤0.01% 2214
2022
Q1
$82.8M Buy
5,966,501
+496,512
+9% +$6.89M ﹤0.01% 2229
2021
Q4
$153M Sell
5,469,989
-120,237
-2% -$3.37M ﹤0.01% 1913
2021
Q3
$190M Buy
5,590,226
+270,369
+5% +$9.19M 0.01% 1739
2021
Q2
$217M Buy
5,319,857
+416,812
+9% +$17M 0.01% 1689
2021
Q1
$197M Sell
4,903,045
-40,894
-0.8% -$1.65M 0.01% 1738
2020
Q4
$292M Sell
4,943,939
-366,973
-7% -$21.7M 0.01% 1320
2020
Q3
$258M Sell
5,310,912
-303,696
-5% -$14.8M 0.01% 1181
2020
Q2
$272M Buy
5,614,608
+653,776
+13% +$31.6M 0.01% 1110
2020
Q1
$138M Buy
4,960,832
+1,802,283
+57% +$50.1M 0.01% 1418
2019
Q4
$94.5M Buy
3,158,549
+1,260,622
+66% +$37.7M ﹤0.01% 1988
2019
Q3
$58.6M Buy
1,897,927
+1,236,944
+187% +$38.2M ﹤0.01% 2184
2019
Q2
$31.9M Buy
+660,983
New +$31.9M ﹤0.01% 2558